tiprankstipranks
Advertisement
Advertisement

PCFPRIM Stock Latest News

F-Prime – Weekly Recap
Private CompaniesF-Prime – Weekly Recap
4d ago
FPRIM
F-Prime Backs $4 Million Seed Round for DeFi Protocol 3F
PremiumPrivate Companies
F-Prime Backs $4 Million Seed Round for DeFi Protocol 3F
4d ago
FPRIM
F-Prime Highlights $4 Million Seed Financing for DeFi Protocol 3F
PremiumPrivate Companies
F-Prime Highlights $4 Million Seed Financing for DeFi Protocol 3F
5d ago
FPRIM
F-Prime Leads $10 Million Seed Financing in Clinical AI Platform Almanac Health
PremiumPrivate Companies
F-Prime Leads $10 Million Seed Financing in Clinical AI Platform Almanac Health
5d ago
FPRIM
F-Prime Leads $10 Million Seed Investment in Clinical AI Platform Almanac Health
PremiumPrivate Companies
F-Prime Leads $10 Million Seed Investment in Clinical AI Platform Almanac Health
6d ago
FPRIM
F-Prime Highlights Early Bet on Gene Therapy Leader RhyGaze Amid Breakthrough Prize Recognition
PremiumPrivate CompaniesF-Prime Highlights Early Bet on Gene Therapy Leader RhyGaze Amid Breakthrough Prize Recognition
7d ago
FPRIM
F-Prime Highlights Portfolio Exposure to Award-Winning Gene Therapy Leadership
Premium
Private Companies
F-Prime Highlights Portfolio Exposure to Award-Winning Gene Therapy Leadership
7d ago
FPRIM
F-Prime Highlights Arts Collaboration Underscoring Innovation and Community Focus
Premium
Private Companies
F-Prime Highlights Arts Collaboration Underscoring Innovation and Community Focus
13d ago
FPRIM
F-Prime Showcases Youth Art Collaboration to Underscore Values-Driven Culture
PremiumPrivate Companies
F-Prime Showcases Youth Art Collaboration to Underscore Values-Driven Culture
14d ago
FPRIM
F-Prime Leadership Participation Highlights Role at USAIC BioPharma & Healthcare Summit
PremiumPrivate Companies
F-Prime Leadership Participation Highlights Role at USAIC BioPharma & Healthcare Summit
21d ago
FPRIM
F-Prime Leadership Engages in USAIC BioPharma & Healthcare Summit
PremiumPrivate Companies
F-Prime Leadership Engages in USAIC BioPharma & Healthcare Summit
22d ago
FPRIM
F-Prime Highlights Portfolio Exposure to Next-Generation Early Cancer Diagnostics
PremiumPrivate Companies
F-Prime Highlights Portfolio Exposure to Next-Generation Early Cancer Diagnostics
26d ago
FPRIM
F-Prime Highlights Portfolio Exposure to DNA Methylation-Based Cancer Diagnostics
PremiumPrivate CompaniesF-Prime Highlights Portfolio Exposure to DNA Methylation-Based Cancer Diagnostics
27d ago
FPRIM
Biogen–Apellis Deal Underscores Ongoing Consolidation in Immunology Biotech
Premium
Private Companies
Biogen–Apellis Deal Underscores Ongoing Consolidation in Immunology Biotech
27d ago
FPRIM
Biogen Acquisition of Apellis Underscores Ongoing Demand for Immunology and Rare-Disease Assets
Premium
Private Companies
Biogen Acquisition of Apellis Underscores Ongoing Demand for Immunology and Rare-Disease Assets
28d ago
FPRIM
Denali Therapeutics Wins First U.S. FDA Approval for Hunter Syndrome Therapy
PremiumPrivate Companies
Denali Therapeutics Wins First U.S. FDA Approval for Hunter Syndrome Therapy
1M ago
FPRIM
FDA Approval of Denali’s AVLAYAH Marks Key Milestone for Rare Disease Platform
PremiumPrivate Companies
FDA Approval of Denali’s AVLAYAH Marks Key Milestone for Rare Disease Platform
1M ago
FPRIM
F-Prime Portfolio Company J‑Pharma Lists on Tokyo Stock Exchange Growth Market
PremiumPrivate Companies
F-Prime Portfolio Company J‑Pharma Lists on Tokyo Stock Exchange Growth Market
1M ago
FPRIM
F-Prime Portfolio Company J-Pharma Lists on Tokyo Stock Exchange Growth Market
PremiumPrivate Companies
F-Prime Portfolio Company J-Pharma Lists on Tokyo Stock Exchange Growth Market
1M ago
FPRIM
F-Prime Participates in £65 Million Series A Financing for Immutrin
PremiumPrivate CompaniesF-Prime Participates in £65 Million Series A Financing for Immutrin
1M ago
FPRIM
F-Prime Backs £65 Million Series A Financing for Cardiology Biotech Immutrin
Premium
Private Companies
F-Prime Backs £65 Million Series A Financing for Cardiology Biotech Immutrin
1M ago
FPRIM
F-Prime Highlights Xaira Therapeutics’ New AI-Driven Virtual Cell Model
Premium
Private Companies
F-Prime Highlights Xaira Therapeutics’ New AI-Driven Virtual Cell Model
1M ago
FPRIM

Trending

Name
Price
Price Change
SPX
S&P 500
―
DJIA
Dow Jones
―
NDX
Nasdaq 100
―
More Trending Stocks >